Cancer Research Institute of the Slovak Academy of Sciences

InstitutionResearch output, impact & collaborations

Cancer Research Institute of the Slovak Academy of Sciences is a research organisation in Bratislava, SK. OpenAlex records 2,393 works and 344,888 citations for it. 571 researchers list it as their most recent affiliation.

2,393

Works

344,888

Citations

571

Researchers

61.2

Avg h-index

IDs:ROR OpenAlex

How has Cancer Research Institute of the Slovak Academy of Sciences's publication output changed over time?

ScholarIQpublication output · 1998–2022

Output grew0% over the shown period — from 1 works in 1998 to 1 in 2022.

1998200520082009201220172018201920202022

What are the most-cited papers on Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQmost cited works

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R. Verneris, Heather E. Stefanski, Gary D. Myers, Muna Qayed, Barbara De Moerloose, Hidefumi Hiramatsu, Krysta Schlis, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Gregory A. Yanik, Christina Peters, André Baruchel, Nicolas Boissel, Françoise Méchinaud, Adriana Balduzzi, Joerg Krueger, Carl H. June, Bruce L. Levine, Patricia A. Wood, Tetiana Taran, Mimi Leung, Karen T. Mueller, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Michael A. Pulsipher, Stephan A. Grupp

New England Journal of Medicine. 20185,720 CitationsOPEN ACCESS

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

Susan L. Cohn, Andrew D.J. Pearson, Wendy B. London, Tom Monclair, Peter F. Ambros, Garrett M. Brodeur, Andreas Faldum, Barbara Hero, Tomoko Iehara, David Machin, Véronique Mosseri, Thorsten Simon, Alberto Garaventa, Victoria Castel, Katherine K. Matthay

Journal of Clinical Oncology. 20081,919 Citations

Long-term efficacy and safety of <i>all-trans</i> retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

Jiong Hu, Yuan-Fang Liu, Chuan-Feng Wu, Fang Xu, Zhi-Xiang Shen, Yong-Mei Zhu, Junmin Li, Wei Tang, Weili Zhao, Wen Wu, Hui-Ping Sun, Qiu-Sheng Chen, Bing Chen, Guang‐Biao Zhou, Arthur Zelent, Samuel Waxman, Zhen-Yi Wang, Sai-Juan Chen, Zhu Chen

Proceedings of the National Academy of Sciences. 2009438 Citations

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

Selim Corbacioglu, Simone Cesaro, Maura Faraci, Dominique Valteau‐Couanet, Bernd Gruhn, Attilio Rovelli, Jaap Jan Boelens, Annette Hewitt, Johanna Schrum, Ansgar Schulz, Ingo Müller, Jerry Stein, Robert Wynn, Johann Greil, Karl-Walter Sykora, Susanne Matthes‐Martin, Monika Führer, Anne O’Meara, Jacek Toporski, Petr Sedláček, Paul G. Schlegel, Karoline Ehlert, Anders Fasth, Jacek Winiarski, Johan Arvidson, Christine Mauz‐Körholz, Hulya Ozsahin, André Schrauder, Peter Bader, Joseph M. Massaro, Ralph B. D’Agostino, Margaret Hoyle, Massimo Iacobelli, Klaus‐Michael Debatin, Christina Peters, Giorgio Dini

The Lancet. 2012376 Citations

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Theodore W. Laetsch, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qayed, Jochen Buechner, Michael A. Pulsipher, Gary Douglas Myers, Heather E. Stefanski, Paul L. Martin, Eneida R. Nemecek, Christina Peters, Gregory A. Yanik, Seong Lin Khaw, Kara L. Davis, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Ranjan Tiwari, Darragh O’Donovan, Stephan A. Grupp

Journal of Clinical Oncology. 2022366 CitationsOPEN ACCESS